Company research
Harvard Apparatus Regenerative Technology, Inc.
CIK 1563665Updated Sep 27, 2026
SecurityHRGN · OTC · equity
Historical securities (1)
EYEGW · NASDAQ · warrant · closed Aug 6, 2020Name history
Biostage, Inc. · through Jul 10, 2023
HRGN price & chart
Loading TradingView…
OTC:HRGN on TradingView ↗In the news
Harvard Apparatus Regenerative Technology Announces First Patient Treated with Cellspan Esophageal Implant at Mayo Clinic ↗
Recent filings
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
D filing
10-Q filing
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
Show 5 more recent filings
Submission of Matters to a Vote of Security Holders
Items 5.07
10-Q filing
Regulation FD Disclosure
Items 7.01, 9.01
DEF 14A filing
Termination of a Material Definitive Agreement
Items 1.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 2,677,000Source | 4,442,000Source | 2,614,000Source | 2,400,000Source |
| Property, Plant and Equipment, NetUSD | 6,000Source | 11,000Source | 25,000Source | 49,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,352,000Source | 2,486,000Source | 432,000Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 16,000Source | 231,000Source | 4,000Source | — |
| Inventory, NetUSD | 16,000Source | 80,000Source | 50,000Source | — |
| Assets, CurrentUSD | 1,829,000Source | 3,234,000Source | 783,000Source | 1,594,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 427,000Source | 347,000Source | 87,000Source | 79,000Source |
| Operating Lease, Right-of-Use AssetUSD | 195,000Source | 293,000Source | 48,000Source | 147,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 1,620,000Source | 1,220,000Source | 968,000Source | 1,411,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 176,000Source | 159,000Source | 139,000Source | 122,000Source |
| Additional Paid in CapitalUSD | 107,450,000Source | 102,757,000Source | 93,463,000Source | 79,698,000Source |
| Retained Earnings (Accumulated Deficit)USD | -106,557,000Source | -99,688,000Source | -91,956,000Source | -83,011,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -12,000Source | -6,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 1,057,000Source | 3,222,000Source | 1,646,000Source | -3,191,000Source |
| Liabilities and EquityUSD | 2,677,000Source | 4,442,000Source | 2,614,000Source | 2,400,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,534,000Source | 1,021,000Source | 968,000Source | 1,363,000Source |
| Operating Lease, Liability, CurrentUSD | 113,000Source | 95,000Source | 48,000Source | 99,000Source |
| Accounts Payable, CurrentUSD | 454,000Source | 452,000Source | 445,000Source | 682,000Source |
| Operating Lease, Liability, NoncurrentUSD | 86,000Source | 199,000Source | — | 48,000Source |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 400,000Source | — |
| Short-term InvestmentsUSD | — | — | 1,200,000Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,010,000Source | 2,402,000Source | 3,461,000Source | 1,031,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -215,000Source | 227,000Source | 4,000Source | — |
| Increase (Decrease) in InventoriesUSD | -64,000Source | 30,000Source | 50,000Source | — |
| Increase (Decrease) in Accounts PayableUSD | — | 7,000Source | -237,000Source | 6,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -3,828,000Source | -4,852,000Source | -6,939,000Source | -5,106,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | 0Source | -11,000Source | -5,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 0Source | 11,000Source | 5,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 2,700,000Source | 6,912,000Source | 6,141,000Source | 5,060,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -1,134,000Source | 2,054,000Source | -809,000Source | -51,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 432,000Source | 1,241,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 9,000Source | 38,000Source | 14,000Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 2,010,000Source | — | — | — |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 400,000Source | — |
| DepreciationUSD | 5,000Source | 14,000Source | 35,000Source | 52,000Source |
| General and Administrative ExpenseUSD | 4,253,000Source | 5,022,000Source | 5,713,000Source | — |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| InterestExpenseNonoperatingUSD | 8,000Source | 38,000Source | — | — |
| Investment Income, InterestUSD | 37,000Source | 32,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -6,869,000Source | -7,732,000Source | -8,945,000Source | -6,073,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | -7,732,000Source | -9,022,000Source | -6,253,000Source |
| Nonoperating Income (Expense)USD | 46,000Source | -6,000Source | 45,000Source | 80,000Source |
| Operating ExpensesUSD | — | — | 9,093,000Source | 6,153,000Source |
| Operating Lease, ExpenseUSD | 132,000Source | 144,000Source | — | — |
| Other Nonoperating Income (Expense)USD | — | 0Source | -5,000Source | -9,000Source |
| Payments to Acquire InvestmentsUSD | — | — | 2,523,000Source | — |
| Proceeds from Issuance of Common StockUSD | 2,700,000Source | 6,482,000Source | 5,992,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | 0Source | 149,000Source | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | 430,000Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 704,000Source | 430,000Source | 103,000Source | — |
| Cost of Goods and Services Sold | — | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | — | 4,411,000Source |
| Operating Income (Loss)USD | -6,915,000Source | -7,726,000Source | -8,990,000Source | -6,153,000Source |
| Other Nonoperating Income (Expense)USD | — | 0Source | -5,000Source | -9,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -6,869,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -6,869,000Source | -7,732,000Source | -8,945,000Source | -6,073,000Source |
| Earnings Per Share, BasicUSD per share | -0.42Source | -0.52Source | -0.67Source | -0.54Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.67Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 16,517,126Source | 14,789,332Source | 13,455,666Source | 11,349,610Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 13,455,666Source | — |
| Interest Expense (non-operating)USD | 8,000Source | 38,000Source | — | — |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 7,619,000Source | 8,156,000Source | — | — |
| Current Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| General and Administrative ExpenseUSD | 4,253,000Source | 5,022,000Source | 5,713,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -6,868,000Source | — | — | — |
| Interest and Other IncomeUSD | — | — | 64,000Source | — |
| Interest ExpenseUSD | — | — | 14,000Source | — |
| Investment Income, InterestUSD | 37,000Source | 32,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | -7,732,000Source | -9,022,000Source | -6,253,000Source |
| Nonoperating Income (Expense)USD | 46,000Source | -6,000Source | 45,000Source | 80,000Source |
| Operating ExpensesUSD | — | — | 9,093,000Source | 6,153,000Source |
| Operating Lease, ExpenseUSD | 132,000Source | 144,000Source | — | — |
| Preferred Stock Dividends and Other AdjustmentsUSD | — | 0Source | — | — |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | 0Source | — | — |
| Research and Development ExpenseUSD | 2,653,000Source | 2,310,000Source | 3,062,000Source | 1,742,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | 430,000Source | — | — |
| Selling and Marketing ExpenseUSD | — | 554,000Source | 294,000Source | — |